AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.672
-0.077 (-10.23%)
Dec 5, 2025, 4:00 PM EST - Market closed
AEON Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | - | - | - | - | - | 2.52 | Upgrade
|
| Revenue | - | - | - | - | - | 2.52 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -24.99% | Upgrade
|
| Gross Profit | - | - | - | - | - | 2.52 | Upgrade
|
| Selling, General & Admin | 11.35 | 13.64 | 19.79 | 13.68 | 11.15 | 11.59 | Upgrade
|
| Research & Development | 5.52 | 14.18 | 33.05 | 34.75 | 25.73 | 7.32 | Upgrade
|
| Operating Expenses | 16.87 | 27.82 | 52.84 | 48.43 | 36.88 | 18.91 | Upgrade
|
| Operating Income | -16.87 | -27.82 | -52.84 | -48.43 | -36.88 | -16.39 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.49 | -34.29 | -17.19 | 0.29 | -0.14 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -5.38 | -62.12 | -70.02 | -48.14 | -37.02 | -16.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.35 | Upgrade
|
| Legal Settlements | 0.4 | - | - | - | -28.97 | - | Upgrade
|
| Other Unusual Items | 4.97 | 104.12 | 33.39 | -4.42 | 10.35 | -16.74 | Upgrade
|
| Pretax Income | -0 | 42.01 | -384.63 | -52.56 | -55.64 | -32.91 | Upgrade
|
| Earnings From Continuing Operations | -0 | 42.01 | -384.63 | -52.56 | -55.64 | -32.91 | Upgrade
|
| Net Income | -0 | 42.01 | -384.63 | -52.56 | -55.64 | -32.91 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 17.26 | Upgrade
|
| Net Income to Common | -0 | 42.01 | -384.63 | -52.56 | -55.64 | -50.17 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 1 | 77 | 2 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 1 | 77 | 2 | 2 | 0 | Upgrade
|
| Shares Change (YoY) | -91.04% | -99.25% | 3896.62% | 9.98% | 1813.85% | -0.74% | Upgrade
|
| EPS (Basic) | -0.00 | 77.74 | -4.99 | -27.25 | -31.73 | -547.60 | Upgrade
|
| EPS (Diluted) | -0.00 | 72.93 | -4.99 | -27.25 | -31.73 | -547.60 | Upgrade
|
| Free Cash Flow | -13.22 | -20.29 | -47.83 | -35.89 | -28.6 | -9.46 | Upgrade
|
| Free Cash Flow Per Share | -1.93 | -35.23 | -0.62 | -18.61 | -16.31 | -103.26 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -650.83% | Upgrade
|
| Profit Margin | - | - | - | - | - | -1992.53% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -375.74% | Upgrade
|
| EBITDA | -16.79 | -27.73 | -52.74 | -48.36 | -36.88 | -15.51 | Upgrade
|
| D&A For EBITDA | 0.08 | 0.1 | 0.1 | 0.07 | 0 | 0.88 | Upgrade
|
| EBIT | -16.87 | -27.82 | -52.84 | -48.43 | -36.88 | -16.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.